Special Alert

Medication Safety Issues with Newly Authorized PAXLOVID
On December 22, 2021, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for PAXLOVID, consisting of oral tablets of nirmatrelvir that are co-packaged with oral t...
Read moreNAN Alert

Age-Related COVID-19 Vaccine Mix-Ups
Ever since the US Food and Drug Administration (FDA) authorized the emergency use of a specific formulation (10 mcg/0.2 mL) of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine for ch...
Read moreArticles

Additional Strategies to Improve Complete Delivery of Small-Volume Intermittent Infusions
In the December 3, 2020 newsletter, ISMP published an article to remind practitioners that up to half of the medication in a 50 mL small-volume intermittent infusion (medication diluted in a small ...
Read moreArticles

A Recurring Call to Action: Every Healthcare Organization Needs a Medication Safety Officer!
Medication safety is a serious responsibility that is vital to the sustainability of healthcare organizations.1 On average, hospitalized patients experience one medication error each day,2,3 and pr...
Read moreArticles

NAN Alert

Dangerous Wrong-Route Errors with Tranexamic Acid
We recently learned about three cases of accidental spinal injection of tranexamic acid instead of a local anesthetic intended for regional (spinal) anesthesia. Container mix-ups were involved in e...
Read moreArticles

Articles

Speaking Up About Patient Safety Requires an Observant Questioner and a High Index of Suspicion
Healthcare practitioners are expected to speak up about patient safety concerns to help intercept errors and avoid adverse patient outcomes. By ‘speaking up,’ we mean raising concerns for the benef...
Read moreArticles

Independent Double Checks: Worth the Effort if Used Judiciously and Properly
Manual independent double checks of certain high-alert medications have been widely promoted in healthcare to help detect potentially harmful errors before they reach patients.1,2 Many practitioner...
Read moreArticles

Dangerous Wrong-Route Errors with Tranexamic Acid—A Major Cause for Concern
Problem: Earlier this month, we were notified about two cases of accidental intraspinal injection of tranexamic acid, occurring in two different states. Unfortunately, the report was sent anonymous...
Read moreArticles

Special Alert

Check for Proper Nucala Dose Preparation
If you are using NUCALA (mepolizumab) for patients who have eosinophilic asthma, please check to ensure the correct volume is being dispensed. In a Safety Brief in our June 28, 2018 newsletter, we ...
Read more